OTC · Biotechnology

Evofem Biosciences, Inc. (EVFM) Stock

$0.01 -4.76% OTC: EVFM Healthcare

Evofem Biosciences, Inc. operates as a biopharmaceutical enterprise dedicated to innovating and bringing to market treatments that address critical underserved areas in women's sexual and reproductive health.

Valuation

MetricValue
Price$0.01
Market Cap$1.06M
P/E Ratio-0.16
P/B Ratio-0.01
P/S Ratio0.05
EPS (TTM)$0.00
52-Week High$0.02
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE8.58%
ROA-81.30%
ROCE4.85%
Gross Margin74.13%
Operating Margin-17.08%
Net Margin-29.90%
Debt/Equity-0.72
Current Ratio0.08

Annual Financials (USD)

Metric20212022202320242025
Revenue$8.0M$17.0M$18.0M$19.0M$20.0M
Operating Profit$-167.0M$-84.0M$-18.0M$-8.0M$1.0M
Net Profit$-205.0M$-77.0M$53.0M$-9.0M$0
EPS$-2962.49$-164.59$0.05$-0.09$0.00
Op Margin-2023.3%-499.6%-98.0%-39.6%7.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$43.0M$25.0M$11.0M$24.0M$20.0M
Total Liabilities$142.0M$97.0M$77.0M$95.0M$90.0M
Cash$8.0M$3.0M$1.0M$1.0M$1.0M
Borrowings$116.0M$71.0M$43.0M$46.0M$55.0M

Latest News

Evofem Biosciences Celebrates Shipment of Its 500,000th Unit of PHEXX®, Representing Hormone-Free Protection from Unintended Pregnancy for 6 Million Acts of Sex Business Wire · Jul 23, 2026 HUB Cyber Security Acquires Evofem Notes, Cuts Staff MT Newswires · Jul 1, 2026 HUB Cyber Security Expands Into Women’s Health With Zero-Cash Acquisition of Evofem Notes, Advances Balance Sheet Turnaround GlobeNewswire · Jul 1, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-147.0M$-70.0M$-9.0M$-4.0M$-2.0M
Investing Cash Flow$-6.0M$-1.0M$0$-1.0M$0
Financing Cash Flow$-1.0M$24.0M$0$0$0
Net Cash Flow$-59.0M$-9.0M$-4.0M$0$0
Free Cash Flow$-150.0M$-71.0M$-9.0M$-4.0M$-2.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-17.34
FCF Yield-24.33%
Quick Ratio0.05
Interest Coverage-5.00
Return 1Y-20.00%
Return 3Y-98.40%
Return 5Y—

Ownership

Insiders Held0.00%
Institutions Held0.00%
Institutions Float Held0.00%
Institutional HolderSharesReport Date
BESSEMER GROUP, INCORPORATED12023-09-30

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About Evofem Biosciences, Inc.

Evofem Biosciences, Inc. operates as a biopharmaceutical enterprise dedicated to innovating and bringing to market treatments that address critical underserved areas in women's sexual and reproductive health. Their leading commercial offering is Phexxi, a vaginal gel specifically designed as a contraceptive. Additionally, the company is actively advancing EVO100, an antimicrobial vaginal gel under development, intended to prevent the urogenital spread of both Chlamydia trachomatis and Neisseria gonorrhoeae infections in women. The company's main office is situated in San Diego, California.

Evofem Biosciences, Inc. is headquartered in US.

Evofem Biosciences, Inc. (EVFM) stock trades at $0.01 with a market capitalization of $1.06M. The stock is valued at a price-to-earnings (P/E) ratio of -0.16, price-to-book of -0.01, price-to-sales of 0.05. Over the past 52 weeks the stock has ranged between $0.00 and $0.02, and currently trades 50.0% below its 52-week high.

On profitability, Evofem Biosciences, Inc. generates a return on equity (ROE) of 8.58%, return on capital employed of 4.85%, an operating margin of -17.08%, a net profit margin of -29.90%.

Official website: www.evofem.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides